AusHealth

What AusHealth does

AusHealth is an Adelaide-headquartered medical research charity established in 1985 and owned by the Central Adelaide Local Health Network (CALHN), with all profits from its commercial operations directed to funding medical research. The organisation operates three commercial divisions — Healthcare Revenue Cycle Management, Clinical Coding, and Drug & Alcohol Testing — that collectively generate revenue in excess of AUD $2 million annually and fund an annual research donation of AUD $4.5 million.

The commercial operations span hospital revenue cycle services (the Accelerator, Mobiliser, and Pathfinder packages for patient liaison, billing, and debt recovery), clinical coding and documentation gap analysis (powered by the CODEXA AI platform developed in partnership with HeartAI), and workplace drug and alcohol testing supported by an in-house training and collection team. Product sales via shop.aushealth.com.au include the AusHealth Helping Hands nitrile glove line, AlcoQuant 6020 breathalysers, Medvet Oral7 drug tests, D95 P2 respirators, L3 surgical masks, infrared thermometers, and COVID-19 antigen tests.

The research arm — operating as AusHealth Ventures from The Accelerator, a 300 sqm innovation hub in Underdale, Adelaide — funds phage therapy for drug-resistant infections, the Platypep GLP-1 peptide program (monotreme venom-derived therapeutics for obesity and Type 2 diabetes), the CBG protein program for septic shock, the CALRmut antibody program for myelofibrosis, and a spider venom project for chronic gut pain. Total cumulative research investment since inception exceeds AUD $50 million, with an annual research fund of approximately AUD $5 million and partnerships spanning the SMART CRC, the Wellspring Consortium, Adelaide University, SAHMRI, the University of Queensland, and EB Research Partnership Australia.

Name

AusHealth

Legal name

AusHealth

Website

https://aushealth.com.au

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

51–100 employees

Short description

AusHealth is an Adelaide-based medical research charity, owned by CALHN, that funds drug discovery and health-tech translation through profits from three commercial divisions: hospital revenue cycle management, clinical coding (CODEXA AI), and workplace drug and alcohol testing, supported by an e-commerce product channel and an Adelaide innovation hub.

Ownership category

akta.pro rank

Product category

Healthcare Revenue Cycle Management Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Health and Welfare Funds (525120)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industry

Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)

Keywords

• Healthcare revenue management
• Clinical coding services
• Drug and alcohol testing
• Workplace safety products
• Medical research funding

Headquarters

HQ city

Adelaide

HQ country

Australia

HQ region

Oceania

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare Revenue Cycle Management Services: Provides patient liaison, billing, revenue management, and debt collection & resolution services to hospitals and healthcare providers across Australia. Generates revenue through service fees charged to healthcare clients for improving their cash flow by recovering outstanding debt.
2. Product Sales (E-commerce): Sells workplace safety and healthcare products including drug testing kits, breathalysers, PPE (gloves, masks, face shields), and medical supplies through its online store (shop.aushealth.com.au). All profits from the AusHealth Helping Hands nitrile glove line fund medical research.
3. Drug & Alcohol Testing Services: Provides on-site drug and alcohol screening, respiratory fit testing, policy development, and training services to workplaces across Australia. Generates revenue through service delivery fees.
4. Clinical Coding Services: Provides clinical coding and documentation gap analysis, Medicare and billing compliance services to hospitals, helping identify financial opportunities, compliance risks and reporting accuracy issues.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

AusHealth is a self-funded medical research charity that delivers three commercial service lines — Healthcare Revenue Cycle Management (patient liaison, billing, debt collection), Clinical Coding Services, and Drug & Alcohol Testing for workplaces — alongside an e-commerce storefront selling PPE, drug testing kits, breathalysers, and nitrile gloves. All commercial profits are channelled into medical research through AusHealth Ventures, funding initiatives such as AI-powered clinical coding (CODEXA), phage therapy, and novel therapeutic discovery.

Product overview

AusHealth is a medical research charity operating three commercial divisions that fund medical research. The core offerings include Healthcare Revenue Cycle Management Services (with Accelerator, Mobiliser, and Pathfinder packages for patient liaison, billing, debt collection, and resolution), Clinical Coding Services, and Drug & Alcohol Testing Services for workplaces. The company also sells workplace safety products including drug testing kits, breathalysers (AlcoQuant 6020), COVID-19 tests (Innoscreen), PPE (D95 masks, L3 surgical masks, face shields), nitrile gloves (AusHealth Helping Hands), and medical supplies (thermometers, cooler bags). AusHealth also operates research initiatives including CODEXA (AI-powered clinical coding software), the AusHealth Phage Therapy Centre, Platypep (venom-based diabetes treatment), CALRmut (antibody therapy for myelofibrosis), and Spider Venom research (chronic pain treatment). The Accelerator innovation hub supports health tech startups, and CureCell Awards fund PhD students in cell and biological therapy.

Differentiator

Problem solved

Functional benefit

Brands

• AusHealth Ventures: Division responsible for medical research funding and spinning out new health tech companies, operating The Accelerator innovation hub
• AusHealth Hospitals
• AusHealth Helping Hands
• The Accelerator
• CODEXA
• CureCell
• Wellspring Consortium

Products and services

• Healthcare Revenue Cycle Management Services Patient liaison, billing, revenue management, and debt collection/resolution services for public and private hospitals, specialist clinics, allied health providers, ambulance and Royal Flying Doctor services, pathology, diagnostic imaging, and aged care facilities across Australia.
• Clinical Coding Services Clinical coding and documentation gap analysis with Medicare and billing compliance identification for hospitals, helping identify financial opportunities, compliance risks, and reporting accuracy for hospital reimbursement.
• Drug and Alcohol Testing Services On-site oral fluid, urine, and hair drug and alcohol testing services for workplaces across Australia, including policy development, supervisor training, and suspicious materials collection and testing.
• Medvet Oral7 Oral Drug Test Oral drug test enabling quick and easy on-site detection of 7 common drugs of abuse in oral fluid for workplace and roadside drug testing procedures.
• AlcoQuant 6020 Breathalyser Series Handheld on-site breathalyser trusted by law enforcement agencies worldwide, delivering accuracy better than +/- 10% as per AS3547. Available in Standard, Download, Passive, and Data Manager variants.
• Innoscreen Covid-19 Antigen Rapid Test Device COVID-19 rapid antigen nasal test kit made in Australia, designed to detect COVID-19 in people without symptoms.
• D95 Mask P2 Respirator Australian-made single-use P2 respirator mask with FitClip for easy dispensing. Filters non-oil-based airborne particles and meets AS/NZS 1716:2012 for Respiratory Protective Devices. Available in 5 sizes.
• L3 Surgical Mask Level 3 single-use surgical mask made in Australia using 98% Australian-sourced material. Designed to meet AS 4381:2015 with BFE 98% and resistance to synthetic blood penetration.
• Anti-fog Reusable Face Shield Durable, lightweight, and reusable full face protection shields. Available in Clear, Blue, Purple, and Polarised variants. Anti-spray, oil splash proof, anti-fogging, and anti-droplets.
• Medical Infrared Forehead Thermometer Non-contact infrared thermometer providing quick and easy temperature screening for humans and objects. Features memory recall for 32 readings and LCD display.
• EVA Insulated Medicine Cooler Bag Rigid insulated cooler bag for transporting temperature-sensitive medical supplies and vaccines. Features built-in thermometer and digital reader, with reusable freezable gel inserts.
• AusHealth Helping Hands Nitrile Gloves 100% nitrile, powder-free disposable gloves meeting Australian standards for medical use. Suitable for hospitals, clinics, laboratories, security, food handling, and beauty care. All proceeds fund medical research.
• CODEXA AI Clinical Coding Software AI-powered software platform built with HeartAI that scans patient clinical notes and uses AI to suggest standardised alphanumeric codes for diagnoses and procedures, with validation rules for Medicare billing compliance. Targets clinical coders in hospitals.

Quantifiable outcome

• Coding time reduced from 20 minutes to 5 minutes for simple cases, and from 2 hours to a fraction of that time for complex 100-page cases, using CODEXA AI
• +4 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature5 records

Partnerships

13 partnerships are on record, tiered core and minor.

• EB Research Partnership Australia (EBRPA)coreStrategic or Co-development Partner · 7 May 2025Collaboration between the AusHealth Phage Therapy Centre and EBRPA to advance phage therapy for treating children with Epidermolysis Bullosa (EB), a rare genetic disorder causing skin to tear and blister. Within months, the partnership resulted in a pilot study with promising results, finding bacteria-killing viruses to annihilate several types of bacteria that commonly infect EB patients.
• SMART CRC (Solutions for Manufacturing Advanced Regenerative Therapies)coreStrategic or Co-development Partner · 28 April 2025AusHealth is one of the architects of the new $238 million cooperative research centre (63 partners contributing $173M + $65M Federal Government) designed to grow Australia's biomanufacturing industry. SMART CRC takes regenerative therapies from laboratory to real world. AusHealth CEO Dr Justin Coombs says SMART CRC will turbocharge work in translating immune therapies for cancer, developing treatments for septic shock, diabetes and metabolic disease. AusHealth and EBRPA are both industry partners in the SMART CRC.
• HeartAIcoreTechnology or Integration · 19 March 2025HeartAI is the AI developer partnered with AusHealth to launch CODEXA, an AI-powered clinical coding software platform. HeartAI's team (led by Lukah Dykes, with Adam Phillips as General Manager, and James Malycha) developed the CODEXA software and continues to optimise it based on coder feedback. HeartAI also develops the CCCIS (CALHN Critical Care Informatics System) AI platform integrated with SA Health's Sunrise EMR.
• University of AdelaidecoreStrategic or Co-development PartnerUniversity of Adelaide is a key research partner across multiple AusHealth-funded projects including CALRmut (antibody therapy for myelofibrosis, partnered with CALHN), The Adelaide Phage Therapy Centre (researching phage therapy for drug-resistant bacteria), Platypep (novel peptides from monotreme venom for obesity and diabetes treatment, partnered with SAHMRI), and Septic Shock/CBG project (led by Professor David Torpy with Associate Professor Richard Young at SAHMRI).
• CALHN (Central Adelaide Local Health Network)coreStrategic or Co-development PartnerCALHN is the hospital network (including Royal Adelaide Hospital, The Queen Elizabeth Hospital, and SA Pathology) that is the shareholder of AusHealth and primary beneficiary of research funding. AusHealth is the sole member of AusHealth Hospital Research Fund (AHRF). AusHealth Ventures is the exclusive commercialisation agent for CALHN. The CALHN Critical Care Informatics System (CCCIS) integrates with SA Health's Sunrise EMR.
• SAHMRI (South Australian Health and Medical Research Institute)coreStrategic or Co-development PartnerSAHMRI is a key research institute collaborating on multiple AusHealth projects: Spider Venom (treating chronic gut pain using spider venom peptides, partnered with University of Queensland), Platypep (partnered with University of Adelaide), and CBG/septic shock project (Associate Professor Richard Young's team at SAHMRI conducted mouse trials).
• University of QueenslandminorStrategic or Co-development PartnerUniversity of Queensland collaborates with AusHealth on the Spider Venom project (Professor Glenn King at UQ collaborated with AusHealth in 2021 to study the bioactivity of monotreme GLP-1 peptides) and the Adelaide Phage Therapy Centre research.
• Adelaide UniversitycoreStrategic or Co-development PartnerAdelaide University was formed from the merger of the University of Adelaide and University of South Australia. It partners with AusHealth on the Phage Therapy Centre and phage therapy research (Professor PJ Wormald, Professor Alkis Psaltis, Professor Sarah Vreugde from the Department of Otolaryngology, Head and Neck Surgery).
• The Florey InstituteminorStrategic or Co-development PartnerThe Florey Institute of Neuroscience and Mental Health partnered with AusHealth through the CureCell Awards program. Matteo Pitteri from The Florey Institute won a $10,000 CureCell Award for his project on unlocking brain-penetrating antisense therapies for neurological diseases.
• Peter MacCallum Cancer CentreminorStrategic or Co-development PartnerPeter MacCallum Cancer Centre partnered with AusHealth through the CureCell Awards program. Kelsy Prest won a $10,000 CureCell Award for her project on a novel platform for precise isolation and molecular profiling of rare MRD-resistant clones driving AML relapse.
• ArdantminorStrategic or Co-development PartnerArdant is a health tech company founded by Margeaux Bartholomew-Carle, an occupational therapist, that connects clients with occupational therapists and handles administrative tasks (scheduling, invoicing, referral management). Ardant joined AusHealth Ventures to access the health tech ecosystem and scale its AI-powered platform for allied health workers.
• Marine Bioproducts CRCminorStrategic or Co-development PartnerMarine Bioproducts CRC partnered with AusHealth CureCell Awards to sponsor the Marine Medical Biotech award category. Giáng Tuyết Phạm from Flinders University received the Marine Bioproducts CRC CureCell Award for a wound healing hydrogel project based on plasma-assisted microalgae extract.
• Pan Macedonian Federation of SAminorStrategic or Co-development PartnerPan Macedonian Federation of SA partnered with AusHealth CureCell Awards as a sponsor. Cate Cheney from SAHMRI received the Pan Macedonian Federation of SA CureCell Award for a project on generating a microbiome-oriented adjuvant therapy for patients with acute lymphoblastic leukemia.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• 3M Health Information Systems: Dominant incumbent in clinical coding and computer-assisted coding (CAC) software globally. Represents the primary competitive benchmark for AusHealth's CODEXA AI clinical coding platform.
• Wellcome Trust: Large UK-based medical research charity that funds scientific research and commercial translation. Comparable to AusHealth as a self-funding research-focused entity, though Wellcome operates at vastly greater scale with a multi-billion endowment.
• Sonic Healthcare: Australian-headquartered global medical diagnostics and pathology provider. Comparable as an Australia-based health services platform operating in adjacent occupational health and clinical testing spaces, though at vastly larger scale.
• Optum (UnitedHealth Group): Largest US health services and innovation company with substantial hospital revenue cycle management, clinical coding, and AI-driven clinical documentation offerings. Comparable to AusHealth's hospital revenue cycle management and clinical coding services, though vastly larger in scale and scope.
• Howard Hughes Medical Institute: Major US biomedical research organisation funding investigator-led science and translation. Comparable in the medical research funding and scientific translation model AusHealth operates, but at substantially larger scale.

Regional players

• Healthscope: Australian private hospital operator. Comparable regional Australian healthcare services context though operates hospitals directly rather than providing revenue cycle and clinical coding services to them.

Emerging players

• Eligo Bioscience: French biotech developing phage-based precision antimicrobials. Comparable emerging player in the engineered phage therapeutics space relevant to AusHealth's natural phage library approach.
• AmpliPhi Biosciences (now Armata Pharmaceuticals): Clinical-stage phage therapy developer targeting antibiotic-resistant infections. Comparable technology platform to AusHealth's Phage Therapy Centre but operates as a publicly traded biotech pursuing commercial therapeutic pathways.
• Adaptive Phage Therapeutics: US-based clinical-stage phage therapy company developing personalised phage treatments for drug-resistant infections. Directly comparable to AusHealth's Phage Therapy Centre in therapeutic approach, though commercially focused versus AusHealth's research-charity model.

Direct peers

• Cure Cell and Gene Therapy Fund / Medical Research Future Fund: Australian federal Medical Research Future Fund (MRFF) is a key funder of the AusHealth Phage Therapy Centre's clinical trial and represents the closest peer in terms of Australian medical research grantmaking and translational funding.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/AusHealthCorporate
• LinkedInlinkedin.com/company/aushealthcorporate

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AusHealth